Legal Representation
Attorney
Richard M. LaBarge
USPTO Deadlines
Next Deadline
42 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20200211)
Due Date
February 11, 2026
Grace Period Ends
August 11, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
30 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 11, 2025 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | Loading... |
| Jan 2, 2021 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Jul 24, 2020 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Jun 2, 2020 | XXSS | O | GENERIC MADRID TRANSACTION SENT TO IB | Loading... |
| Jun 2, 2020 | XXCR | P | GENERIC MADRID TRANSACTION CREATED | Loading... |
| May 11, 2020 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Feb 11, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 26, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 26, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 6, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 20, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 15, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 14, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 14, 2019 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Sep 30, 2019 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Sep 30, 2019 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Sep 30, 2019 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Sep 25, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 25, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 18, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 13, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 1, 2019 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| May 15, 2019 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| May 14, 2019 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Apr 23, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Apr 22, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 21, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 16, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Apr 12, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 11, 2019 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Active chemical ingredients for use in industry, namely the pharmaceutical industry
Class 005
pharmaceutical preparations for preventing or treating immune system related diseases and disorders; pharmaceutical products for preventing or treating cancer
Class 042
Medical research; biotechnology research; pharmaceutical research and development
Additional Information
Design Mark
The mark consists of a stylized letter "K" formed primarily of four dots. Each of the dots in the upper row is connected to the dot on the lower left, and that dot mixes the shadings of the two connected dots.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
KEZAR
Classification
International Classes
001
005
042